{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:53:22Z","timestamp":1790175202698,"version":"4.1.0"},"reference-count":115,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T00:00:00Z","timestamp":1720396800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100015516","name":"Ontario Agri-Food Innovation Alliance","doi-asserted-by":"publisher","award":["UG-T1-2023-102251"],"award-info":[{"award-number":["UG-T1-2023-102251"]}],"id":[{"id":"10.13039\/501100015516","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["RGPIN 2019-06110"],"award-info":[{"award-number":["RGPIN 2019-06110"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Veterinary Immunology and Immunopathology"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.vetimm.2024.110803","type":"journal-article","created":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T22:11:39Z","timestamp":1720044699000},"page":"110803","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["The mRNA vaccine platform for veterinary species"],"prefix":"10.1016","volume":"274","author":[{"given":"Fatemeh","family":"Fazel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janan Shoja","family":"Doost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sugandha","family":"Raj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitish","family":"Boodhoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalil","family":"Karimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shayan","family":"Sharif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vetimm.2024.110803_bib1","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.matt.2021.12.022","article-title":"Oral mRNA delivery using capsule-mediated gastrointestinal tissue injections","volume":"5","author":"Abramson","year":"2022","journal-title":"Matter"},{"key":"10.1016\/j.vetimm.2024.110803_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2021.654289","article-title":"Novel vaccine technologies in veterinary medicine: a herald to human medicine vaccines","volume":"8","author":"Aida","year":"2021","journal-title":"Front. Vet. Sci."},{"key":"10.1016\/j.vetimm.2024.110803_bib3","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/s41565-019-0591-y","article-title":"The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs","volume":"14","author":"Akinc","year":"2019","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.vetimm.2024.110803_bib4","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/mt.2010.85","article-title":"Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms","volume":"18","author":"Akinc","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.vetimm.2024.110803_bib5","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1016\/j.immuni.2021.11.001","article-title":"Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses","volume":"54","author":"Alameh","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.vetimm.2024.110803_bib6","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jconrel.2015.08.051","article-title":"N1-methylpseudouridine-incorporated mRNA outperforms pseudouridine-incorporated mRNA by providing enhanced protein expression and reduced immunogenicity in mammalian cell lines and mice","volume":"217","author":"Andries","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.vetimm.2024.110803_bib7","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.trsl.2021.12.006","article-title":"An mRNA vaccine to prevent genital herpes","volume":"242","author":"Awasthi","year":"2022","journal-title":"Transl. Res."},{"key":"10.1016\/j.vetimm.2024.110803_bib8","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.ymthe.2017.03.035","article-title":"Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses","volume":"25","author":"Bahl","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.vetimm.2024.110803_bib9","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1038\/mt.2011.190","article-title":"Influence of cationic lipid composition on gene silencing properties of lipid nanoparticle formulations of siRNA in antigen-presenting cells","volume":"19","author":"Basha","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.vetimm.2024.110803_bib10","first-page":"161","article-title":"mRNA-based dendritic cell vaccines","author":"Benteyn","year":"2014","journal-title":"Expert Rev. Vaccin."},{"key":"10.1016\/j.vetimm.2024.110803_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/vaccines9020097","article-title":"An update on self-amplifying mRNA vaccine development","volume":"9","author":"Blakney","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.vetimm.2024.110803_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13567-016-0404-3","article-title":"Marek\u2019s disease in chickens: a review with focus on immunology","volume":"47","author":"Boodhoo","year":"2016","journal-title":"Vet. Res."},{"key":"10.1016\/j.vetimm.2024.110803_bib13","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1016\/j.cimid.2010.05.002","article-title":"Replicon particle vaccine protects swine against influenza","volume":"33","author":"Bosworth","year":"2010","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"key":"10.1016\/j.vetimm.2024.110803_bib14","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1038\/mt.2014.133","article-title":"A cationic nanoemulsion for the delivery of next-generation RNA vaccines","volume":"22","author":"Brito","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.vetimm.2024.110803_bib15","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1586\/14760584.2015.990890","article-title":"Electroporation-enhanced delivery of nucleic acid vaccines","volume":"14","author":"Broderick","year":"2014","journal-title":"Expert Rev. Vaccin."},{"key":"10.1016\/j.vetimm.2024.110803_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/vaccines9010061","article-title":"Immune responses induced by mrna vaccination in mice, monkeys and humans","volume":"9","author":"Cagigi","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.vetimm.2024.110803_bib17","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1038\/nsb874","article-title":"Structural basis of m7GpppG binding to the nuclear cap-binding protein complex","volume":"9","author":"Calero","year":"2002","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.vetimm.2024.110803_bib18","first-page":"1397","article-title":"Characterization of a messenger RNA polynucleotide vaccine vector","volume":"55","author":"Conry","year":"1995","journal-title":"Cancer Res"},{"key":"10.1016\/j.vetimm.2024.110803_bib19","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.virusres.2016.08.005","article-title":"Status of vaccines for porcine epidemic diarrhea virus in the United States and Canada","volume":"226","author":"Crawford","year":"2016","journal-title":"Virus Res"},{"key":"10.1016\/j.vetimm.2024.110803_bib20","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3390\/vaccines8010106","article-title":"Broad Protection of Pigs against Heterologous PRRSV Strains by a GP5-Mosaic DNA Vaccine Prime\/GP5-Mosaic rVaccinia (VACV) Vaccine Boost","volume":"8","author":"Cui","year":"2020","journal-title":"Vaccines"},{"key":"10.1016\/j.vetimm.2024.110803_bib21","doi-asserted-by":"crossref","first-page":"6077","DOI":"10.1073\/pnas.86.16.6077","article-title":"Cationic liposome-mediated RNA transfection","volume":"86","author":"Dwarki","year":"1989","journal-title":"Proc. Nati Acad. Sci. USA"},{"key":"10.1016\/j.vetimm.2024.110803_bib22","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/nature04001","article-title":"Apolipoprotein-mediated pathways of lipid antigen presentation","volume":"437","author":"Elzen","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.vetimm.2024.110803_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.virol.2023.109970","article-title":"Efficacy and tolerability of an mRNA vaccine expressing gB and pp38 antigens of Marek\u2019s disease virus in chickens","volume":"590","author":"Fazel","year":"2024","journal-title":"Virology"},{"key":"10.1016\/j.vetimm.2024.110803_bib24","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1016\/j.vaccine.2019.04.074","article-title":"mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials","volume":"37","author":"Feldman","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vetimm.2024.110803_bib25","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1177\/014107680609900320","article-title":"The cutter incident: how America\u2019s first polio vaccine led to a growing vaccine crisis advantages","volume":"99","author":"Fitzpatrick","year":"2006","journal-title":"J. R. Soc. Med."},{"key":"10.1016\/j.vetimm.2024.110803_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.601626","article-title":"Biodegradable polymeric nanoparticles for drug delivery to solid tumors","volume":"12","author":"Gagliardi","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.vetimm.2024.110803_bib27","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1101\/gad.5.11.2108","article-title":"The cap and poly (A) tail function synergistically to regulate mRNA translational efficiency","author":"Gallie","year":"1991","journal-title":"Genes Dev."},{"key":"10.1016\/j.vetimm.2024.110803_bib28","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.vetmic.2016.11.029","article-title":"Vaccines for porcine epidemic diarrhea virus and other swine coronaviruses","volume":"206","author":"Gerdts","year":"2017","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.vetimm.2024.110803_bib29","unstructured":"Gladue, D., 2023. Development of a Self-amplifying mRNA Vaccine for African Swine Fever and Classical Swine Fever [WWW Document]. Agric. Res. Serv. URL \u3008https:\/\/www.ars.usda.gov\/research\/project\/?accnNo=440187\u3009."},{"key":"10.1016\/j.vetimm.2024.110803_bib30","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/gt.2017.5","article-title":"Nanotechnologies in delivery of mRNA therapeutics using nonviral vector-based delivery systems","volume":"24","author":"Guan","year":"2017","journal-title":"Gene Ther."},{"key":"10.1016\/j.vetimm.2024.110803_bib31","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.tips.2017.01.003","article-title":"Cell-penetrating peptides: from basic research to clinics","volume":"38","author":"Guidotti","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.vetimm.2024.110803_bib32","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.tips.2017.01.003","article-title":"Cell-penetrating peptides: from basic research to clinics","volume":"38","author":"Guidotti","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.vetimm.2024.110803_bib33","doi-asserted-by":"crossref","first-page":"E9153","DOI":"10.1073\/pnas.1810002115","article-title":"mRNA vaccination with charge-altering releasable transporters elicits human T cell responses and cures established tumors in mice","volume":"115","author":"Haabeth","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.vetimm.2024.110803_bib34","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13567-020-00762-4","article-title":"Intranasally administered protein coated chitosan nanoparticles encapsulating influenza H9N2 HA2 and M2e mRNA molecules elicit protective immunity against avian influenza viruses in chickens","volume":"51","author":"Hajam","year":"2020","journal-title":"Vet. Res."},{"key":"10.1016\/j.vetimm.2024.110803_bib35","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1172\/JCI0214364","article-title":"Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors","volume":"109","author":"Heiser","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.vetimm.2024.110803_bib36","first-page":"1","article-title":"mRNA in cancer immunotherapy: beyond a source of antigen","volume":"20","author":"Hoecke","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.vetimm.2024.110803_bib37","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/ni.2350","article-title":"Virus-cell fusion as a trigger of innate immunity dependent on the adaptor STING","volume":"13","author":"Holm","year":"2012","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.vetimm.2024.110803_bib38","first-page":"4009","article-title":"Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells","volume":"108","author":"Holtkamp","year":"2006","journal-title":"Gene Ther."},{"key":"10.1016\/j.vetimm.2024.110803_bib39","doi-asserted-by":"crossref","first-page":"8180","DOI":"10.1016\/j.vaccine.2007.09.038","article-title":"Development and preclinical evaluation of an alphavirus replicon vaccine for influenza","volume":"25","author":"Hubby","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vetimm.2024.110803_bib40","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1080\/17425247.2022.2131767","article-title":"Are inhaled mRNA vaccines safe and effective? A review of preclinical studies","volume":"19","author":"Jansen","year":"2022","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.vetimm.2024.110803_bib41","doi-asserted-by":"crossref","first-page":"8529","DOI":"10.1002\/anie.201203263","article-title":"Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo","volume":"51","author":"Jayaraman","year":"2012","journal-title":"Angew. Chem. - Int. Ed."},{"key":"10.1016\/j.vetimm.2024.110803_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.vetmic.2020.108886","article-title":"Immunogenicity and protective efficacy induced by an mRNA vaccine encoding gD antigen against pseudorabies virus infection","volume":"251","author":"Jiang","year":"2020","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.vetimm.2024.110803_bib43","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/j.vaccine.2018.01.029","article-title":"Multi-antigenic human cytomegalovirus mRNA vaccines that elicit potent humoral and cell-mediated immunity","volume":"36","author":"John","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vetimm.2024.110803_bib44","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1038\/mt.2008.200","article-title":"Incorporation of Pseudouridine Into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability","volume":"16","author":"Karik\u00f3","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.vetimm.2024.110803_bib45","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jconrel.2015.12.032","article-title":"Materials for non-viral intracellular delivery of messenger RNA therapeutics","volume":"240","author":"Kauffman","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.vetimm.2024.110803_bib46","doi-asserted-by":"crossref","first-page":"3882","DOI":"10.1016\/j.vaccine.2016.05.046","article-title":"Self-adjuvanted mRNA vaccines induce local innate immune responses that lead to a potent and boostable adaptive immunity","volume":"34","author":"Kowalczyk","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vetimm.2024.110803_bib47","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.ymthe.2019.02.012","article-title":"Delivering the messenger: advances in technologies for therapeutic mRNA delivery","volume":"27","author":"Kowalski","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.vetimm.2024.110803_bib48","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1371\/journal.pbio.0040180","article-title":"High guanine and cytosine content increases mRNA levels in mammalian cells","volume":"4","author":"Kudla","year":"2006","journal-title":"PLoS Biol."},{"key":"10.1016\/j.vetimm.2024.110803_bib49","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00262-006-0222-y","article-title":"T cell responses in melanoma patients after vaccination with tumor-mRNA transfected dendritic cells","volume":"56","author":"Kyte","year":"2007","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.vetimm.2024.110803_bib50","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/imm.12505","article-title":"CD8 T-cell priming upon mRNA vaccination is restricted to bone-marrow-derived antigen-presenting cells and may involve antigen transfer from myocytes","volume":"146","author":"Lazzaro","year":"2015","journal-title":"Immunology"},{"key":"10.1016\/j.vetimm.2024.110803_bib51","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1242\/jcs.1995.Supplement_19.2","article-title":"The influence of 5\u2019 and 3\u2019 end structures on pre-mRNA metabolism","volume":"108","author":"Lewis","year":"1995","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.vetimm.2024.110803_bib52","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1016\/j.ymthe.2017.08.006","article-title":"Efficient targeting and activation of antigen-presenting cells in vivo after modified mRNA vaccine administration in rhesus macaques","volume":"25","author":"Liang","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.vetimm.2024.110803_bib53","doi-asserted-by":"crossref","first-page":"281","DOI":"10.7150\/thno.35568","article-title":"RNA nanotechnology-mediated cancer immunotherapy","volume":"10","author":"Lin","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.vetimm.2024.110803_bib54","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.molmed.2019.10.002","article-title":"Tailoring mRNA vaccine to balance innate\/adaptive immune response","volume":"26","author":"Linares-Fern\u00e1ndez","year":"2020","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.vetimm.2024.110803_bib55","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1586\/14760584.2015.957685","article-title":"The ReNAissanCe of mRNA-based cancer therapy","volume":"14","author":"Lint","year":"2014","journal-title":"Expert Rev. Vaccin."},{"key":"10.1016\/j.vetimm.2024.110803_bib56","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1002\/ange.201710144","article-title":"Engineering multifunctional RNAi nanomedicine to concurrently target cancer hallmarks for combinatorial therapy","volume":"130","author":"Liu","year":"2018","journal-title":"Angew. Chem."},{"key":"10.1016\/j.vetimm.2024.110803_bib57","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ymthe.2017.10.020","article-title":"Combination immunotherapy of MUC1 mRNA Nano-vaccine and CTLA-4 blockade effectively inhibits growth of triple negative breast cancer","volume":"26","author":"Liu","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.vetimm.2024.110803_bib58","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.nano.2013.12.003","article-title":"Cationic lipid nanocarriers activate Toll-like receptor 2 and NLRP3 inflammasome pathways","volume":"10","author":"Lonez","year":"2014","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.vetimm.2024.110803_bib59","first-page":"100","article-title":"Redox-responsive nanoparticle-mediated systemic RNAi for effective cancer therapy","volume":"176","author":"M. Christopher","year":"2016","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.vetimm.2024.110803_bib60","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3390\/vaccines5030018","article-title":"Egg-independent influenza vaccines and vaccine candidates","volume":"5","author":"Manini","year":"2017","journal-title":"Vaccines"},{"key":"10.1016\/j.vetimm.2024.110803_bib61","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1098\/rsif.2007.0220","article-title":"Natural origin biodegradable systems in tissue engineering and regenerative medicine: present status and some moving trends","volume":"4","author":"Mano","year":"2007","journal-title":"J. R. Soc. Interface"},{"key":"10.1016\/j.vetimm.2024.110803_bib62","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1002\/eji.1830230749","article-title":"Induction of virus-specific cytotoxic T lymphocytes in vivo by liposome-entrapped mRNA","volume":"23","author":"Martinon","year":"1993","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.vetimm.2024.110803_bib63","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41577-019-0243-3","article-title":"Novel vaccine technologies for the 21st century","volume":"20","author":"Mascola","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.vetimm.2024.110803_bib64","doi-asserted-by":"crossref","first-page":"735","DOI":"10.3390\/vaccines2040735","article-title":"Self-Amplifying replicon RNA vaccine delivery to dendritic cells by synthetic nanoparticles","volume":"2","author":"Mccullough","year":"2014","journal-title":"Vaccines"},{"key":"10.1016\/j.vetimm.2024.110803_bib65","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.4155\/tde.12.90","article-title":"Functional RNA delivery targeted to dendritic cells by synthetic nanoparticles","volume":"3","author":"McCullough","year":"2012","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.vetimm.2024.110803_bib66","doi-asserted-by":"crossref","first-page":"E5859","DOI":"10.1073\/pnas.1805358115","article-title":"Enhanced mRNA delivery into lymphocytes enabled by lipid-varied libraries of charge-altering releasable transporters","volume":"115","author":"McKinlay","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.vetimm.2024.110803_bib67","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/infdis\/jix592","article-title":"Modified mRNA-based vaccines elicit robust immune responses and protect guinea pigs from ebola virus disease","volume":"217","author":"Meyer","year":"2018","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vetimm.2024.110803_bib68","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/s41587-019-0247-3","article-title":"Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation","volume":"37","author":"Miao","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.vetimm.2024.110803_bib69","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.imlet.2022.10.002","article-title":"Comparison of three different COVID-19 vaccine platforms (CoronaVac, BTN162b2, and Ad5-nCoV) in individuals with and without prior COVID-19: reactogenicity and neutralizing antibodies","volume":"251\u2013252","author":"Morales-N\u00fa\u00f1ez","year":"2022","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.vetimm.2024.110803_bib70","first-page":"1","article-title":"Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA","volume":"39","author":"Muramatsu","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.vetimm.2024.110803_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.103479","article-title":"The mRNA-LNP platform\u2019s lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory","volume":"24","author":"Ndeupen","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.vetimm.2024.110803_bib72","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1242\/jcs.00073","article-title":"On the importance of being co-transcriptional","volume":"115","author":"Neugebauer","year":"2002","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.vetimm.2024.110803_bib73","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/1439-7633(20010601)2:6<457::AID-CBIC457>3.0.CO;2-F","article-title":"Towards proto-cells: \u201cPrimitive\u201d lipid vesicles encapsulating giant DNA and its histone complex","volume":"2","author":"Nomura","year":"2001","journal-title":"ChemBioChem"},{"key":"10.1016\/j.vetimm.2024.110803_bib74","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2011.3","article-title":"Systemic RNAi-mediated gene silencing in nonhuman primate and rodent myeloid cells","volume":"1","author":"Novobrantseva","year":"2012","journal-title":"Mol. Ther. - Nucleic Acids"},{"key":"10.1016\/j.vetimm.2024.110803_bib75","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.3390\/vaccines10101572","article-title":"Efficacy, Immunogenicity, and Safety of COVID-19 vaccines in randomized control trials in the pre-delta era: a systematic review and network meta-analysis","volume":"10","author":"Oh","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.vetimm.2024.110803_bib76","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.coi.2020.01.008","article-title":"Recent advances in mRNA vaccine technology","volume":"65","author":"Pardi","year":"2020","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.vetimm.2024.110803_bib77","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines-a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.vetimm.2024.110803_bib78","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jconrel.2015.08.007","article-title":"Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes","volume":"217","author":"Pardi","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.vetimm.2024.110803_bib79","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jconrel.2018.10.015","article-title":"PECAM-1 directed re-targeting of exogenous mRNA providing two orders of magnitude enhancement of vascular delivery and expression in lungs independent of apolipoprotein E-mediated uptake","volume":"291","author":"Parhiz","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.vetimm.2024.110803_bib80","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1038\/nbt.2436","article-title":"Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection","volume":"30","author":"Petsch","year":"2012","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.vetimm.2024.110803_bib81","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.vetimm.2009.10.008","article-title":"Novel approaches to vaccination against the feline immunodeficiency virus","volume":"134","author":"Pistello","year":"2010","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.vetimm.2024.110803_bib82","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 Vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.vetimm.2024.110803_bib83","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.1128\/JVI.01836-08","article-title":"Attenuated foot-and-mouth disease virus RNA carrying a deletion in the 3 \u0458 noncoding region can elicit immunity in swine","volume":"83","author":"Pulido","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.vetimm.2024.110803_bib84","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/rmv.360","article-title":"Alphavirus vectors and vaccination","volume":"12","author":"Rayner","year":"2002","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.vetimm.2024.110803_bib85","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.antiviral.2009.12.005","article-title":"RNA immunization can protect mice against foot-and-mouth disease virus","volume":"85","author":"Rodr\u00edguez","year":"2010","journal-title":"Antivir. Res"},{"key":"10.1016\/j.vetimm.2024.110803_bib86","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1177\/0300985813501341","article-title":"Respiratory syncytial virus infection in cattle","volume":"51","author":"Sacco","year":"2014","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.vetimm.2024.110803_bib87","first-page":"222","article-title":"Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer","volume":"547","author":"Sahin","year":"2017","journal-title":"Nat. Publ. Group"},{"key":"10.1016\/j.vetimm.2024.110803_bib88","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0092-8674(85)90132-1","article-title":"mRNA cap binding proteins: essential factors for initiating translation","volume":"40","author":"Shatkin","year":"1985","journal-title":"Cell"},{"key":"10.1016\/j.vetimm.2024.110803_bib89","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nrc.2016.108","article-title":"Cancer nanomedicine: progress, challenges and opportunities","volume":"17","author":"Shi","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.vetimm.2024.110803_bib90","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.addr.2012.01.018","article-title":"Stimuli-responsive polymers and nanomaterials for gene delivery and imaging applications","volume":"64","author":"Shim","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.vetimm.2024.110803_bib91","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.addr.2012.01.018","article-title":"Stimuli-responsive polymers and nanomaterials for gene delivery and imaging applications","volume":"64","author":"Shim","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.vetimm.2024.110803_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2020.104648","article-title":"Nonclinical safety assessment of repeated administration and biodistribution of a novel rabies self-amplifying mRNA vaccine in rats","volume":"113","author":"Stokes","year":"2020","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.vetimm.2024.110803_bib93","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1021\/mp100390w","article-title":"In vitro and in vivo mRNA delivery using lipid-enveloped pH-responsive polymer nanoparticles","volume":"8","author":"Su","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.vetimm.2024.110803_bib94","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1182\/blood.V66.5.1149.1149","article-title":"Half-lives of beta and gamma globin messenger RNAs and of protein synthetic capacity in cultured human reticulocytes","volume":"66","author":"Sullivan","year":"1985","journal-title":"Blood"},{"key":"10.1016\/j.vetimm.2024.110803_bib95","doi-asserted-by":"crossref","DOI":"10.1038\/srep34215","article-title":"A tetravalent sub-unit dengue vaccine formulated with ionizable cationic lipid nanoparticle induces significant immune responses in rodents and non-human primates","volume":"6","author":"Swaminathan","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.vetimm.2024.110803_bib96","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.vaccine.2015.10.132","article-title":"A novel lipid nanoparticle adjuvant significantly enhances B cell and T cell responses to sub-unit vaccine antigens","volume":"34","author":"Swaminathan","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vetimm.2024.110803_bib97","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/s41590-022-01160-y","article-title":"IL-1 and IL-1ra are key regulators of the inflammatory response to RNA vaccines","volume":"23","author":"Tahtinen","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.vetimm.2024.110803_bib98","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1002\/eji.200737998","article-title":"DiC14-amidine cationic liposomes stimulate myeloid dendritic cells through Toll-like receptor 4","volume":"38","author":"Tanaka","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.vetimm.2024.110803_bib99","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1038\/mt.2015.103","article-title":"Sequence-engineered mRNA without chemical nucleoside modifications enables an effective protein therapy in large animals","volume":"23","author":"Thess","year":"2015","journal-title":"Am. Soc. Gene Cell Ther."},{"key":"10.1016\/j.vetimm.2024.110803_bib100","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1093\/clinchem\/48.10.1647","article-title":"Stability of Endogenous and Added RNA in Blood Specimens, Serum, and Plasma","volume":"48","author":"Tsui","year":"2002","journal-title":"Clin. Chem."},{"key":"10.1016\/j.vetimm.2024.110803_bib101","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.ijbiomac.2016.02.004","article-title":"Chitin and chitosan based polyurethanes: a review of recent advances and prospective biomedical applications","volume":"86","author":"Usman","year":"2016","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.vetimm.2024.110803_bib102","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.1016\/j.celrep.2018.11.082","article-title":"An mRNA vaccine protects mice against multiple article an mRNA vaccine protects mice against multiple tick-transmitted flavivirus infections","volume":"25","author":"Vanblargan","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.vetimm.2024.110803_bib103","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1016\/j.vaccine.2012.01.030","article-title":"Safety, immunogenicity, and efficacy of an alphavirus replicon-based swine influenza virus hemagglutinin vaccine","volume":"30","author":"Vander Veen","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vetimm.2024.110803_bib104","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-018-06936-1","article-title":"Cell specific delivery of modified mRNA expressing therapeutic proteins to leukocytes","volume":"9","author":"Veiga","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.vetimm.2024.110803_bib105","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.immuni.2022.10.014","article-title":"Innate immune mechanisms of mRNA vaccines","volume":"55","author":"Verbeke","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.vetimm.2024.110803_bib106","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nantod.2019.100766","article-title":"Nano today three decades of messenger RNA vaccine development","volume":"28","author":"Verbeke","year":"2019","journal-title":"Nano Today"},{"key":"10.1016\/j.vetimm.2024.110803_bib107","unstructured":"Verhoeven, D., 2021. Novel mRNA vaccine technology for prevention of bovine respiratory syncytial virus - Iowa State University [WWW Document]. United State Dev. Agric. URL \u3008https:\/\/portal.nifa.usda.gov\/web\/crisprojectpages\/1027610-novel-mrna-vaccine-technology-for-prevention-of-bovine-respiratory-syncytial-virus.html\u3009 (accessed 7.28.23)."},{"key":"10.1016\/j.vetimm.2024.110803_bib108","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.ymthe.2017.11.017","article-title":"Self-Amplifying RNA vaccines give equivalent protection against influenza to mRNA vaccines but at much lower doses","volume":"26","author":"Vogel","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.vetimm.2024.110803_bib109","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/sj.gt.3302213","article-title":"Detection of integration of plasmid DNA into host genomic DNA following intramuscular injection and electroporation","volume":"11","author":"Wang","year":"2004","journal-title":"Gene Ther."},{"key":"10.1016\/j.vetimm.2024.110803_bib110","doi-asserted-by":"crossref","unstructured":"Weide, B., Pascolo, S., Scheel, B., Derhovanessian, E., Pflugfelder, A., Eigentler, T.K., Pawelec, G., Hoerr, I., Rammensee, H., Garbe, C., 2009. Direct Injection of Protamine-protected mRNA: Melanoma Patients 32, 498\u2013507. https:\/\/doi.org\/10.3390\/v15040977.","DOI":"10.1097\/CJI.0b013e3181a00068"},{"key":"10.1016\/j.vetimm.2024.110803_bib111","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0959-437X(97)80132-3","article-title":"Life and death in the cytoplasm: messages from the 3\u2019 end","volume":"7","author":"Wickens","year":"1997","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.vetimm.2024.110803_bib112","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1126\/science.1690918","article-title":"Direct gene transfer into mouse muscle in vivo","volume":"247","author":"Wolff","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.vetimm.2024.110803_bib113","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1016\/j.cell.2022.05.022","article-title":"Humoral and cellular immune memory to four COVID-19 vaccines","volume":"185","author":"Zhang","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.vetimm.2024.110803_bib114","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.3109\/10717544.2015.1038856","article-title":"Induction of HIV-1 gag specific immune responses by cationic micelles mediated delivery of gag mRNA","volume":"23","author":"Zhao","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.vetimm.2024.110803_bib115","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1529\/biophysj.107.113472","article-title":"Binding and clustering of glycosaminoglycans: a common property of mono- and multivalent cell-penetrating compounds","volume":"94","author":"Ziegler","year":"2008","journal-title":"Biophys. J."}],"container-title":["Veterinary Immunology and Immunopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165242724000898?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165242724000898?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T11:15:13Z","timestamp":1778670913000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165242724000898"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":115,"alternative-id":["S0165242724000898"],"URL":"https:\/\/doi.org\/10.1016\/j.vetimm.2024.110803","relation":{},"ISSN":["0165-2427"],"issn-type":[{"value":"0165-2427","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The mRNA vaccine platform for veterinary species","name":"articletitle","label":"Article Title"},{"value":"Veterinary Immunology and Immunopathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vetimm.2024.110803","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"110803"}}